1-3 of 3
Bernd Gaede
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective and Safe Deferasirox Treatment of Patients with Various anemia's and Transfusional Iron-Overload in the Medical Practice: Results From Two German Observational Studies

Christian Junghanss, MD, Rudolf Schlag, MD, Bernd Gaede, MD, Matthias Moelle, MD, Steffen Doerfel, Frank Heits, MD, Ulrike Haus, PhD, Alexia Junkes, PhD, Oliver Leismann, PhD
Journal: Blood
Blood (2011) 118 (21): 5165.
https://doi.org/10.1182/blood.V118.21.5165.5165
Published: 2011
Journal Articles

Intravenous (IV) Iron Supplementation in Patients with Chemotherapy-Induced Anemia (CIA) Receiving Darbepoetin alfa Every 3 Weeks (Q3W): Iron Parameters in a Randomized Controlled Trial.

Christian Lerchenmueller, MD, Faress Husseini, MD, Bernd Gaede, MD, Tony Mossman, Tamas Suto, MD, An Vanderbroek, MD
Journal: Blood
Blood (2006) 108 (11): 1552.
https://doi.org/10.1182/blood.V108.11.1552.1552
Published: 2006
Journal Articles

Bendamustine/Mitoxantrone/Rituximab (BMR): A Very Effective and Well Tolerated Immuno-Chemotherapy for Relapsed and Refractory Indolent Lymphomas - Results of a Multicentre Phase-II-Study of the German Low Grade Lymphoma Study Group ( GLSG ).

Rudolf Weide, Hubert Koeppler, Jochen Heymanns, Joerg Thomalla, Georg Hess, Heinhold Gamm, Ali Aldaoud, Stephan Schmitz, Ursula Haak, Dirk Plewe, Oswald Burkhard, Bernd Gaede, Fokke Hinrichs, Karl-Heinz Pflueger, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2004) 104 (11): 2482.
https://doi.org/10.1182/blood.V104.11.2482.2482
Published: 2004